ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.

GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...

South African President Cyril Ramaphosa spoke with Elon Musk a day after U.S. President Donald Trump promised to cut the ...

A spokesman for President Javier Milei says he has ordered Argentina’s withdrawal from the World Health Organization due to profound differences with the U.N. agency. Milei’s action echoes that of ...